Blood Cancer UK | Tests for acute myeloid leukaemia (AML) (2024)

Some people are told they might have AML after going to their GP with symptoms and having a blood test called a ‘full blood count’. If your blood results suggest that AML is a possibility, you might be phoned and told to come to hospital urgently. Most people need to start treatment very quickly, within a day or two.

Other people visit A&E as an emergency because they suddenly get very unwell and don’t know why. They’ll be checked in A&E and have tests, and they might be told in hospital or soon afterwards about the possibility of AML.

A full blood count measures the number of each type of cell in the blood – red blood cells, white blood cells and platelets. In AML, you can have too many of some blood cells, and not enough of others.

A sample of blood will be taken from a vein in your arm and sent to the lab for testing.

If you’re diagnosed with AML, you’ll have regular FBCs to monitor your condition. Find out more about blood counts in AML and what the results mean.

A blood film means taking a sample of your blood to look at under a microscope. This allows the doctors to see if you have any leukaemia cells in your blood, and what they look like.

If doctors suspect AML, one of the first things they’ll want to check is whether you have a subtype of AML called APL, which has different treatments. APL cells look different to AML cells under the microscope. If you have APL, read our information about acute promyelocytic leukaemia (APL).

AML begins in the bone marrow, so checking the bone marrow for leukaemia cells is an important test. This is one of the main tests used to confirm a diagnosis of AML.

Bone marrow is a soft, spongy tissue found in the centre of large bones. It is where the body makes its blood cells.

A bone marrow biopsy involves removing a sample of bone marrow from your hip bone. This can be looked at under a microscope.

AML is usually diagnosed if the number of myeloid blasts (immature blood cells) in your bone marrow is 20% or more.

We have more information about bone marrow biopsies.

Tests can be done on a sample of your blood or bone marrow, to look for any changes (mutations) in the chromosomes or DNA in the abnormal cells. Sometimes these results can confirm a diagnosis of AML. They can also help your doctor plan the most effective treatment, as some mutations can be targeted by specific drugs.

These tests are sometimes called cytogenetic testing, karyotyping or FISH testing (all tests that look for changes in chromosome structure) and molecular genetics, PCR and sequencing tests (all tests that look for DNA sequence changes).

Find out more about genetic mutations and AML.

If you are diagnosed with AML, you’ll have a general health check. This will help work out your risk of side effects from treatment, and whether high-intensity or low-intensity treatment might be best.

You’ll have a range of tests to check your general health, including your heart, liver and kidney function, and tests for HIV and hepatitis B and hepatitis C. You’ll probably have a combination of blood tests and other tests such as a chest x-ray, ECG (electrical tracing of the heart) and echocardiogram (heart ultrasound).

Your healthcare team will talk to you about what the results of these tests mean for your treatment.

Not everyone needs a stem cell transplant, but if your doctor thinks there is a chance you might need one in the future, they might talk to you about tissue typing. This means first doing tests to confirm your own tissue type, and then considering whether to start looking for a bone marrow donor whose tissue type closely matches yours. This might involve testing your siblings or looking for matches on bone marrow donor registries.

Even if you might not need a stem cell transplant, your doctor might talk to you about tissue typing, just in case you come to need a transplant later.

We explain more about stem cell transplants in the high-intensity treatment information.

We have more general information about other tests that are often used in blood cancer.